JP2010539915A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539915A5
JP2010539915A5 JP2010526268A JP2010526268A JP2010539915A5 JP 2010539915 A5 JP2010539915 A5 JP 2010539915A5 JP 2010526268 A JP2010526268 A JP 2010526268A JP 2010526268 A JP2010526268 A JP 2010526268A JP 2010539915 A5 JP2010539915 A5 JP 2010539915A5
Authority
JP
Japan
Prior art keywords
repeat
armadillo repeat
armadillo
protein
collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010526268A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/062671 external-priority patent/WO2009040338A1/en
Publication of JP2010539915A publication Critical patent/JP2010539915A/ja
Publication of JP2010539915A5 publication Critical patent/JP2010539915A5/ja
Pending legal-status Critical Current

Links

JP2010526268A 2007-09-24 2008-09-23 設計されたアルマジロリピートタンパク質 Pending JP2010539915A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07117059 2007-09-24
PCT/EP2008/062671 WO2009040338A1 (en) 2007-09-24 2008-09-23 Designed armadillo repeat proteins

Publications (2)

Publication Number Publication Date
JP2010539915A JP2010539915A (ja) 2010-12-24
JP2010539915A5 true JP2010539915A5 (enExample) 2011-10-13

Family

ID=38962601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010526268A Pending JP2010539915A (ja) 2007-09-24 2008-09-23 設計されたアルマジロリピートタンパク質

Country Status (5)

Country Link
US (1) US9365629B2 (enExample)
EP (1) EP2198022B1 (enExample)
JP (1) JP2010539915A (enExample)
CA (1) CA2700391A1 (enExample)
WO (1) WO2009040338A1 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2323695B1 (en) 2008-08-19 2018-12-05 Nektar Therapeutics Complexes of small-interfering nucleic acids
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP2643349B1 (en) 2010-11-26 2019-09-04 Molecular Partners AG Designed repeat proteins binding to serum albumin
KR20190089048A (ko) 2011-02-15 2019-07-29 이뮤노젠 아이엔씨 컨쥬게이트의 제조방법
SG10201605041VA (en) 2011-06-21 2016-08-30 Immunogen Inc Novel maytansinoid derivatives with peptide linker and conjugates thereof
EP2887965A1 (en) 2012-08-22 2015-07-01 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
US9901647B2 (en) 2013-02-28 2018-02-27 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014134483A2 (en) 2013-02-28 2014-09-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014194030A2 (en) 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
NZ758715A (en) 2013-10-31 2023-01-27 Seattle Children’S Hospital Dba Seattle Children’S Res Institute Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
SG11201605046YA (en) 2013-12-20 2016-07-28 Hutchinson Fred Cancer Res Tagged chimeric effector molecules and receptors thereof
US10665324B2 (en) 2014-07-07 2020-05-26 Yeda Research And Development Co. Ltd. Method of computational protein design
US9381256B2 (en) 2014-09-03 2016-07-05 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
US9669102B2 (en) 2014-09-03 2017-06-06 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
ES2979088T3 (es) 2015-03-05 2024-09-24 Fred Hutchinson Cancer Center Proteínas de fusión inmunomoduladoras y usos de las mismas
US9458211B1 (en) 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
US20180355318A1 (en) 2015-04-29 2018-12-13 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
WO2016176652A2 (en) 2015-04-29 2016-11-03 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
WO2017106728A2 (en) * 2015-12-16 2017-06-22 University Of Washington Repeat protein architectures
EP4711465A2 (en) 2016-04-14 2026-03-18 Fred Hutchinson Cancer Center Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
AR109680A1 (es) 2016-09-22 2019-01-09 Molecular Partners Ag Proteínas recombinantes y sus usos
CN110461335A (zh) 2017-02-17 2019-11-15 弗雷德哈钦森癌症研究中心 用于治疗bcma相关癌症和自身免疫性失调的联合疗法
RU2022101392A (ru) 2017-02-28 2022-03-02 Иммуноджен, Инк. Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты
WO2018165046A1 (en) 2017-03-07 2018-09-13 Igc Bio, Inc. A computational pipeline for antibody modeling and design
US11725210B2 (en) 2017-03-17 2023-08-15 Fred Hutchinson Cancer Center Immunomodulatory fusion proteins and uses thereof
WO2018195243A1 (en) 2017-04-20 2018-10-25 Immunogen, Inc. Cytotoxic benzodiazepine derivatives and conjugates thereof
TW202413360A (zh) 2017-12-28 2024-04-01 美商伊繆諾金公司 苯二氮平衍生物
EP3849565A4 (en) 2018-09-12 2022-12-28 Fred Hutchinson Cancer Research Center REDUCTION OF CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
TW202102270A (zh) 2019-03-21 2021-01-16 美商伊繆諾金公司 製備細胞結合劑-藥物結合物之方法
CN113661172A (zh) 2019-03-29 2021-11-16 伊缪诺金公司 用于抑制异常细胞生长或治疗增生性疾病的细胞毒性双苯并二氮杂䓬衍生物及其与细胞结合剂的缀合物
EP3958977B1 (en) 2019-04-26 2023-09-13 ImmunoGen, Inc. Camptothecin derivatives
AU2020286600A1 (en) 2019-06-04 2021-12-23 Molecular Partners Ag Recombinant FAP binding proteins and their use
EP3980452A1 (en) 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
CA3138805A1 (en) 2019-06-04 2020-12-10 Johannes Schilling Designed ankyrin repeat domain with improved stability
SG11202111943UA (en) 2019-07-02 2021-11-29 Hutchinson Fred Cancer Res Recombinant ad35 vectors and related gene therapy improvements
CN114929730A (zh) 2019-12-11 2022-08-19 分子合作伙伴股份公司 重组肽-mhc复合物结合蛋白及其生成和用途
WO2021116470A2 (en) 2019-12-11 2021-06-17 Molecular Partners Ag Recombinant peptide-mhc complex binding proteins and their generation and use
US20230142283A1 (en) * 2020-03-05 2023-05-11 University Of Washington Rigid helical junctions for modular repeat protein sculpting and methods of use
MX2022013945A (es) 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
JP2023528204A (ja) 2020-05-14 2023-07-04 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
US20240279309A1 (en) 2020-05-14 2024-08-22 Molecular Partners Ag Recombinant cd40 binding proteins and their use
WO2022130300A1 (en) 2020-12-16 2022-06-23 Molecular Partners Ag Novel slow-release prodrugs
KR20230120139A (ko) 2020-12-16 2023-08-16 몰리큘라 파트너스 아게 재조합 cd3 결합 단백질 및 이의 용도
EP4304730A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Novel darpin based cd33 engagers
AU2022233791A1 (en) 2021-03-09 2023-09-28 Molecular Partners Ag Novel darpin based cd123 engagers
JP2024509904A (ja) 2021-03-09 2024-03-05 モレキュラー パートナーズ アクチェンゲゼルシャフト 新規なDARPinに基づく多重特異性T細胞エンゲージャ
US20240156980A1 (en) 2021-03-09 2024-05-16 Molecular Partners Ag Protease cleavable prodrugs
IL313411A (en) 2021-12-14 2024-08-01 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
WO2023131707A1 (en) * 2022-01-07 2023-07-13 Universität Zürich Stabilizing n-cap sequences for armadillo repeat proteins
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
CN119731200A (zh) 2022-08-01 2025-03-28 分子合作伙伴股份公司 经电荷修饰设计的重复结构域及其用途
WO2024179981A1 (en) 2023-02-27 2024-09-06 Molecular Partners Ag Darpins for use in reducing renal accumulation of drugs
WO2024251695A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd47 binding proteins and their use
WO2024251628A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
CN121263440A (zh) 2023-06-06 2026-01-02 分子合作伙伴股份公司 重组cd2结合蛋白及其用途
WO2025068607A1 (en) * 2023-09-29 2025-04-03 Universität Zürich Modular armadillo repeat proteins
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
WO2025146487A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Multispecific binding proteins
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
WO2025146490A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Recombinant cd117 binding proteins and their use
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
US20250332297A1 (en) 2024-01-31 2025-10-30 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2025245169A1 (en) 2024-05-21 2025-11-27 Fred Hutchinson Cancer Center Immunotherapy cells equipped with a collagen-targeting payload

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2421447C (en) * 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
US20060115813A1 (en) * 2001-06-08 2006-06-01 Incyte Corporation Intracellular signaling molecules
US7049482B1 (en) * 2004-11-30 2006-05-23 Korea Kumho Petrochemical Co., Ltd. Nucleic acid molecule encoding an armadillo repeat protein, aria and a method utilizing aria to generate salt tolerant plants

Similar Documents

Publication Publication Date Title
JP2010539915A5 (enExample)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
JP2014501510A5 (enExample)
RU2013128896A (ru) Сконструированные белки повторов, которые связываются с сывороточным альбумином
JP2017518072A5 (enExample)
JP2009529509A5 (enExample)
MX357674B (es) Polipeptidos biosinteticos de espira aleatoria de prolina/alanina y sus usos.
WO2007133623A3 (en) Peptide diagnostic agent for lyme disease
ATE443161T1 (de) Mittel und verfahren für den nachweis von methylierter dna
JP2018508492A5 (enExample)
JP2011511933A5 (enExample)
JP2017530099A5 (enExample)
JP2019526248A5 (enExample)
JP2009268467A5 (enExample)
CY1116011T1 (el) Hla-a*1101-περιορισμενο wt1 πεπτιδιο και φαρμακευτικη συνθεση που το περιλαμβανει
JP2010529860A5 (enExample)
WO2009004315A8 (en) Isolated peptides and uses thereof
FI3750552T3 (fi) Gdf-loukkuja
WO2008031133A3 (en) Borrelia antigens
WO2011154420A3 (en) Tear lipocalin muteins binding il-4 r alpha
RU2012114662A (ru) Модифицированные убиквитиновые белки со специфической связывающей активностью для экстрадомена "в" фибронектина
CA2398155A1 (en) Methods and compositions for linking binding domains in nucleic acid binding proteins
WO2011063003A3 (en) Peptides and methods for the detection of lyme disease antibodies
PT2450436E (pt) Quimera da polimerase de dna do fago phi 29
RU2016104651A (ru) Устойчивые к протеазам пептидные лиганды